D-0577-2023 Class II Ongoing

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0577-2023 was initiated by RemedyRepack Inc. on May 1, 2023 and is designated Class II. Reason for recall: CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or… The recall status is ongoing. Affected quantity: 12 5mL bottles.

Recall details

Product Type
Drugs
Report Date
May 24, 2023
Initiation Date
May 1, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12 5mL bottles

Product description

Ketotifen Fumarate 0.025 %, Antihistamine eye drops, 5mL bottle, MFG: Akorn, Lake Forrest IL 60045, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-1142-00; Source NDC # 17477-0717-10;

Reason for recall

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Distribution pattern

Product was distrituded to three direct account in PA.

Code information

Lot # B1643789-041022, EXP 03/31/2024; B1894150-100722, B1891573-100622, EXP. 7/31/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0577-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0577-2023. Report a data issue: hello@regdatalab.com.